Ampyra (fampridine-SR)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ampyra (fampridine-SR), covering 2012-02-27 to 2012-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial [Phase 3]